CLOUDBREAK THERAPEUTICS LLC has a total of 49 patent applications. It decreased the IP activity by 61.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and medical technology are PLACE VIRGIL A, THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG CHINESE MEDICAL UNIV and ZHENGZHOU SAIKE PHARMACEUTICAL TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 5 | |
#4 | Canada | 5 | |
#5 | EPO (European Patent Office) | 5 | |
#6 | China | 4 | |
#7 | Republic of Korea | 4 | |
#8 | Brazil | 3 | |
#9 | Mexico | 3 | |
#10 | Hong Kong | 2 | |
#11 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Ni Jinsong | 43 |
#2 | Yang Rong | 26 |
#3 | Whitcup Scott | 7 |
#4 | Jinsong Ni | 6 |
#5 | Rong Yang | 4 |
#6 | Dinh Van | 3 |
#7 | Tien Walter | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021050692A2 | Methods for alleviating pterygium-associated worry about eye appearance | |
US10744153B1 | Compositions and methods for treating meibomian gland dysfunction | |
AU2019333093A1 | Emulsion formulations of multikinase inhibitors | |
KR20210013574A | Composition for treating ocular congestion and method for treating ocular congestion using the same | |
EP3630161A1 | A topical composition for treating rosacea and a method for treating rosacea with the same | |
US2020323844A1 | Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization | |
CN108135737A | For treating pteryium composition and method |